Cord Blood America CEO Discusses New State-of-the-Art State Laboratory in Fox News Television Interview

Cord Blood America CEO Discusses New State-of-the-Art State Laboratory in Fox News Television Interview

SANTA MONICA, Calif. and LAS VEGAS, July 22 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (BULLETIN BOARD: CBAI) , one of the largest umbilical cord blood stem cell preservation companies (http://www.cordblood-america.com/) focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today that its founder and CEO Matthew Schissler was featured on Monday in a television interview on KVVU Fox News Las Vegas, in which he discusses the 17,000 square foot facility in Las Vegas, Nevada that it recently leased to develop a state-of-the-art laboratory for the storage of multiple stem cell products including umbilical cord blood stem cells.

"Since we announced earlier this month that we had leased the Facility, there has been tremendous interest from parties in the Western United States in discussing opportunities to partner with the Company," said Mr. Schissler. "In addition to our current cord blood stem cell business, we are excited about having the capability to process and store multiple forms of stem cells, and expect to begin generating different revenue streams from the sale of these services in early 2010."

The entire interview is available at www.cordblood-america.com.

About Cord Blood America

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI - News), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.

Click here to view social media version of this release.

Click here to visit the Cord Blood America Social Media Newsroom.

Forward-Looking Statements

Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company's performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.

CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com

Source: Cord Blood America, Inc.

CONTACT: Paul Knopick of E & E Communications, +1-949-707-5365,
pknopick@eandecommunications.com, for Cord Blood America, Inc.

Web Site: http://www.cordblood-america.com/

-------
Profile: intent